MissionIR Articles
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO), Ohio State New Tech Featured in Newly Installed Food Processing Equipment
Pressure BioSciences (OTCQB: PBIO), a Massachusetts-based company that manufactures high pressure-based equipment and laboratory instrumentation for the life sciences industry, has been working with The Ohio State University College of Food, Agricultural, and Environmental Sciences…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Shares Innovative Applications of Pressure on The Stock Day Podcast
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and services to the worldwide life sciences, food and beverage, nutraceuticals and other industries, was featured…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Key Milestone in Commercialization of Ultra Shear Technology(TM)
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and process development services to the worldwide food and beverage, biotherapeutics and personal wellness industries, among others,…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Innovations and Advancements in the CBD Market Webinar
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and services to the worldwide food and beverage, biotherapeutics and personal wellness industries, among others, today…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Scalable UST(TM) Process Shown to Create Rock-Solid 18-Month Stability
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and innovative services to the worldwide biotechnology, biotherapeutics, cosmetics, nutraceuticals, agrochemical, and food and beverage industries.…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q3 2021 Financial Report
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, has…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Second US Patent for Innovative UST(TM) Platform, NanoGap(TM) Valve
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialized services to the worldwide life sciences and other key industries, today announced the award of…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) BaroFold Platform Brings Key Capabilities Amid Strong Demand for Protein Therapeutics
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, high pressure-based instruments, platform technologies and related consumables for the worldwide life sciences, agriculture, food and beverage, and other key…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at First-of-Its-Kind Benzinga ALL ACCESS Investor Event
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and services to the worldwide life sciences and other key industries, today announced its participation in Benzinga’s…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Changes Neem Oil into Novel Nanoemulsion through Patented UST Platform
Pressure BioSciences’ (OTCQB: PBIO) patented Ultra Shear Technology(TM) (“UST”) platform has produced stable, high-quality neem oil nanoemulsions. The nanoemulsions are designed to provide safe, natural, and environmentally friendly pesticides, which can be used to mitigate…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Upcoming Small Cap Conferences
Pressure BioSciences (OTCQB: PBIO) has announced that it will be presenting at both the Benzinga Healthcare Conference and the Emerging Growth Small Cap Conference. PBIO is a leader in the development and sale of broadly…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Strong Q2 2021 Results, Eyes Highly Successful Remainder of 2021
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide life sciences and other key industries, today announced continued strong…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Presenting at Emerging Growth Conference
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide life sciences and other key industries, has announced its participation…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Sees More than $1M in Orders in First Month
Pressure BioSciences (OTCQB: PBIO) announced that PBI Agrochem Inc., its new subsidiary, has received purchase orders totaling more than $1 million in its first month of operation. Agrochem provides ecofriendly agrochemical products, and the orders…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Growth Plan, Goal for Remainder of 2021
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, has announced…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Business Model Expected to Generate up to $3M in Incremental Revenue
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life science and other industries, recently announced the development of the ultra-potent antioxidant astaxanthin (“AsX”) as an extremely fine and uniform…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Establishes New Subsidiary, Provides Update on Anticipated Acquisition
Pressure BioSciences (OTCQB: PBIO) has established a wholly owned agrochemicals subsidiary; the subsidiary will be named PBI Agrochem Inc. and is designed to house the announced asset acquisition from Global Agrochemicals Innovator. PBIO previously announced…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured in Recent Stock Day Podcast Discussing CBD Nanoemulsion Milestones
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, was featured in a recent episode of the Stock Day…
-
Powerful Antioxidant Nanoemulsion Development Lights Up the Profile of Pressure BioSciences Inc. (PBIO)
Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) specializes in the use of ultra-high pressure technologies to innovate unexpected and potent solutions for a wide variety of industries, including biomarker and target discovery, forensics, counter-bioterror…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UST(TM) Platform Delivers Breakthrough Results Processing One of the Most Powerful Antioxidants Known to Science
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology and other industries, today announced the successful application of…
Search Articles
Latest Articles
- FAVO Capital Inc. (FAVO): When Private Credit Meets Real Estate Collateralization
- AI and the Copper Conundrum: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Fits into the Supply Equation
- Silvercorp Metals Inc. (NYSE-A/TSX: SVM) El Domo Environmental License Upheld as Ecuador’s Constitutional Court Dismisses Final Challenge
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
- MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option